News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analysts recommend buying Pfizer at $35 with a $50 target, citing cash flow and pipeline catalysts.
  • GitLab recommended long on AI-driven demand and ~42% ARR growth, with a mid-term trade setup.
  • M/I Homes recommended buy based on low leverage, free cash flow, and ~11 P/E.
  • Recommended trades include defined entry, stop, and target levels across 46–180 trading-day horizons.
  • Analyst activity covers pharma, AI-exposed software, and homebuilding, highlighting stock-specific opportunities.
  • Overall sentiment: positive; all hourly recommendations are buy-focused across sectors.

Latest Articles

BONK, INC. Director Expands Indirect Equity Stake Amid Valuation Debate

BONK, INC. Director Expands Indirect Equity Stake Amid Valuation Debate

Rudy Mitchell Austin, a director and significant 10% shareholder of BONK, INC. (NASDAQ:BNKK), has increased his indirect ownership in the company. The acquisition, executed through Nom Capital ULC, brings his total holdings to 85,000 shares. This move occurs against a backdrop of significant stock price depreciation over the past year and recent re…

Hims & Hers CFO Executes Pre-Arranged Stock Sale Under Rule 10b5-1 Plan

Hims & Hers CFO Executes Pre-Arranged Stock Sale Under Rule 10b5-1 Plan

Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc., executed a series of transactions involving the company’s Class A Common Stock on July 6, 2026. The CFO exercised stock options and subsequently sold 7,163 shares through a Rule 10b5-1 trading plan established on May 21, 2025. The sale, valued at approximately $261,351, occurred at…

Twilio CFO Viggiano Executes $1.75M Stock Sale Under Pre-Arranged Plan

Twilio CFO Viggiano Executes $1.75M Stock Sale Under Pre-Arranged Plan

Aidan Viggiano, Chief Financial Officer at Twilio Inc. (NASDAQ: TWLO), sold 8,528 shares of the company’s Class A common stock for $1,751,907 on July 2, 2026, according to a filing with the Securities and Exchange Commission. The sale was conducted under a pre-arranged 10b5-1 trading plan established on June 6, 2025. Following the transaction, Vigg…

MIAX Executive Executes Planned Stock Transactions Amid Exchange Growth

MIAX Executive Executes Planned Stock Transactions Amid Exchange Growth

Jayabalan Harish, Executive Vice President, Chief Information Security Officer, and Chief Risk Officer at Miami International Holdings, Inc. (NASDAQ: MIAX), executed a series of stock transactions on July 6, 2026. The executive sold 20,000 shares valued at $842,400 while simultaneously acquiring 20,000 shares through the exercise of nonqualified st…

HRT Financial LP Acquires Wheeler REIT Shares Amid Sharp Decline

HRT Financial LP Acquires Wheeler REIT Shares Amid Sharp Decline

HRT Financial LP, a significant shareholder in Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR), executed recent purchases of the company's common stock totaling $25,880. The acquisitions span a wide price range from $0.0814 to $1.39 per share, taking place against a backdrop of severe stock depreciation and active corporate restructuring.…

AIRO Group Holdings Executive Offloads Shares Amid Operational Shifts

AIRO Group Holdings Executive Offloads Shares Amid Operational Shifts

John Uczekaj, President and Chief Operating Officer of AIRO Group Holdings, Inc. (NASDAQ: AIRO), executed a transaction on July 6, 2026, selling 154 shares of common stock. The sale, valued at $1,195, was conducted to satisfy tax withholding obligations linked to the vesting of restricted stock units. Following this divestment, Uczekaj's direct own…

Vertex Pharmaceuticals Executive Offloads Shares Under Pre-Arranged Plan

Vertex Pharmaceuticals Executive Offloads Shares Under Pre-Arranged Plan

Ourania Tatsis, Executive Vice President and Chief Regulatory & Quality Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), executed a sale of company stock totaling $787,485 on July 2, 2026. The transaction involved the disposition of 1,500 shares at $524.99 per share, leaving her with a direct holding of 45,321 shares. The sale was conducted un…

Butterfly Network Executive Disposes of Shares Amid Expansion Initiatives

Butterfly Network Executive Disposes of Shares Amid Expansion Initiatives

Butterfly Network, Inc. (NASDAQ: BFLY) reported a recent transaction involving its Chief Accounting Officer and Senior Vice President of Finance, Megan Carlson, who sold 41,303 shares of Class A Common Stock on July 2, 2026. The transaction, totaling $328,937, was executed under a sell-to-cover policy to meet tax withholding requirements associated…

Transocean Ltd. Announces Second Quarter 2026 Earnings Release Date

Transocean Ltd. Announces Second Quarter 2026 Earnings Release Date

Transocean Ltd. will report its second quarter 2026 earnings and provide a fleet status update on August 5, 2026, after market close. The company will host a teleconference on August 6, 2026, to discuss the results. Transocean is a leading offshore drilling services provider with a focus on ultra-deepwater and harsh environment operations, operatin…

Oracle: A Rare Buy Zone As AI Demand Meets Execution Risk

Oracle: A Rare Buy Zone As AI Demand Meets Execution Risk

Oracle is trading well below its recent peak despite 17% revenue growth and a booming cloud-infrastructure business. The stock is oversold technically and priced for execution failure: that combination creates a tradeable long with defined risk and asymmetric upside if AI demand and backlog convert as management forecasts.

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

Wave Life Sciences Ltd. announced that the Singapore High Court will hold a hearing on July 14, 2026 to approve the company's proposed redomiciliation from Singapore to the United States via a scheme of arrangement. The company has already secured requisite shareholder approval for this move, which remains subject to court approval and other closin…

Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

Lifeward Ltd., a biomedical innovation company specializing in neurorehabilitation products and therapeutic platforms, announced a strategic financing agreement to raise up to $11.2 million in convertible notes and warrants. This funding supports accelerating commercialization efforts of its restorative healthcare technologies, including the ReWalk…

Wealthfront Reports June 2026 Monthly Metrics

Wealthfront Reports June 2026 Monthly Metrics

Wealthfront Corporation reported monthly operational metrics for June 2026, with total platform assets reaching a record $99.1 billion. Investment Advisory Assets increased by 33% year-over-year to $54.3 billion, driven by strong net deposits and higher cross-product adoption. The company also saw growth in funded clients by 15% year-over-year, und…